iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapy-Reference-Cited by-同舟云学术

iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapy

Published:2021-03 Issue: Volume:20 Page:572-586
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Brücher Dominik,Kirchhammer Nicole,Smith Sheena N.,Schumacher Jatina,Schumacher Nina,Kolibius Jonas,Freitag Patrick C.,Schmid Markus,Weiss Fabian,Keller Corina,Grove Melanie,Greber Urs F.,Zippelius Alfred,Plückthun Andreas

Funder

Universität Zürich

National Cancer Institute

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference72 articles.

1. Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities;Sedighi;Cancer Med.,2019

2. Advances in stem cell research and therapeutic development;De Luca;Nat. Cell Biol.,2019

3. Designer oncolytic adenovirus: coming of age;Baker;Cancers (Basel),2018

4. State-of-the-art human adenovirus vectorology for therapeutic approaches;Gao;FEBS Lett.,2019

5. Viral vectors in gene therapy;Lundstrom;Diseases,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DARPin-fused T cell engager for adenovirus-mediated cancer therapy;Molecular Therapy: Oncology;2024-09

2. Dendritic cell targeting in lymph nodes with engineered modular adapters improves HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21;2024-04-28

3. Targeting Antheraea pernyi silk fibroin modified dual-gene coexpressing vector enhances gene transport and promotes lung tumor suppression;International Journal of Biological Macromolecules;2024-03

4. Gutless Helper-Dependent and First-Generation HAdV5 Vectors Have Similar Mechanical Properties and Common Transduction Mechanisms;Human Gene Therapy;2024-03-01

5. Targeting HIV-1 with CRISPR/Cas9 delivered by retargeted adenoviruses effectively suppresses viral replication;2023-12-18